Andre Godin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Andre godin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Andre Godin Today - Breaking & Trending Today

IntelGenx Announces First Parkinson's Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 'MONTPARK' Clinical Trial -April 08, 2024 at 07:45 am EDT

SAINT LAURENT, Quebec, April 08, 2024 IntelGenx Corp. today announced that Montelukast VersaFilm® has been administered to the first Parkinson’s Disease patients in the Phase 2 clinical. ....

United States , Saint Laurent , Dwight Gorham , Stephen Kilmer , Andre Godin , Montelukast Versafilm , Exchange Commission , Intelgenx Corp , Drug Administration , Swedish University , Intelgenx Technologies Corp , World Health Organization , Parkinson Foundation , Securities Exchange , Karolinska University Hospital , Company Or Intelgenx , Per Svenningsson , Lead Principal , Health Organization , Leukotriene Receptor Antagonist Montelukast , Looking Information , Securities Exchange Act , Securities Act , United States Securities , Intelgenx Technologies ,

IntelGenx Announces First Parkinson's Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ?MONTPARK' Clinical Trial

IntelGenx Announces First Parkinson's Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ?MONTPARK' Clinical Trial
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Saint Laurent , United States , Montelukast Versafilm , Stephen Kilmer , Andre Godin , Dwight Gorham , Intelgenx Technologies Corp , Company Or Intelgenx , Intelgenx Corp , Exchange Commission , Swedish University , Parkinson Foundation , Karolinska University Hospital , World Health Organization , Securities Exchange , Drug Administration , Genx Announces First Parkinson , Disease Patients Dosed , Per Svenningsson , Lead Principal , Health Organization , Leukotriene Receptor Antagonist Montelukast , Looking Information , Securities Exchange Act , Securities Act , United States Securities ,

IntelGenx Updates Status of Buprenorphine Buccal Film ANDA

SAINT LAURENT, Quebec, April 05, 2024 IntelGenx Corp. today announced that its co-developer, Chemo Research SL, through its agent and affiliate, Xiromed LLC , has received a Complete Response. ....

Saint Laurent , Stephen Kilmer , Dwight Gorham , Andre Godin , Intelgenx Versafilm , Company Or Intelgenx , Intelgenx Corp , Intelgenx Technologies Corp , Securities Exchange , Drug Administration , Chemo Research , Complete Response Letter , Buprenorphine Buccal , Pharmaceutical Quality , Buccal Film , Looking Information , Securities Exchange Act , Securities Act , Intelgenx Technologies ,

IntelGenx Enters Into a Third Amended and Restated Loan Agreement With atai Life Sciences

SAINT LAURENT, Quebec, March 11, 2024 IntelGenx Technologies Corp. announces that its wholly-owned subsidiary, IntelGenx Corp. , has entered into a third amended and restated loan agreement. ....

Saint Laurent , United States , Andre Godin , Stephen Kilmer , Toronto Stock Exchange , Intelgenx Corp , National Instrument , Intelgenx Technologies Corp , Life Sciences , Party Transactions , Securities Exchange , Securities Of The Company , Exchange Commission , Company The , Company Or Intelgenx , Genx Technologies , Genx Corp , Loan Agreement , Second Tranche Loan , Additional Term Loans , First Tranche Loan , Conversion Price , Multilateral Instrument , Minority Security Holders , Special Transactions , Early Warning System ,

UPDATE -- IntelGenx Launches Preferred Share Regulation A Offering

SAINT LAURENT, Quebec, Feb. 20, 2024 IntelGenx Corp. today announced the launch of a Regulation A offering of up to 2,000,000 shares of Series A Convertible Cumulative Preferred Stock , par. ....

Saint Laurent , United States , Dwight Gorham , Stephen Kilmer , Andre Godin , Intelgenx Technologies Corp , Company Or Intelgenx , Intelgenx Corp , United States Securities Exchange , Exchange Commission , Toronto Stock Exchange , Digital Offering , Convertible Cumulative Preferred Stock , Preferred Stock , Toronto Stock , United States Securities Act , Preliminary Offering Circular , Offering Statement , United States Securities Exchange Act , Intelgenx Technologies ,